How is it going? Today I bring you some news that sounds like science fiction but is about to become a reality: Life Biosciences is going to start “soon” the first clinical trial in humans of a cell reprogramming technology to treat blindness.
Cell reprogramming is a technique that basically allows you to “reset” cells to a younger and more functional state. In this specific case, it will be used to try to restore vision in people with serious eye problems. It is a powerful and promising technology that has given good results in the laboratory, and now comes the moment of truth: testing it on human volunteers.
What makes this trial so relevant is not only its potential to treat blindness, but what it represents for the field of rejuvenation in general. If it works, we could be looking at the beginning of a new era in regenerative medicine. Obviously we have to be cautious and wait for the results, but the anticipation is enormous.
We will follow very closely how this trial evolves. It could be historic.
